Back

Ticagrelor versus Prasugrel in Patients Undergoing Invasive Management of Coronary Artery Disease

31 August 2026 (14:30 - 14:45)
Organised by: Logo
Congress Presentation Part of: Better decisions in coronary revascularisation Antiplatelet Drugs ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Daniele Giacoppo

AOU Policlinico - G. Rodolico San Marco, Catania (Italy)

3 More presentations in this session

Presentation thumbnail
Two-Year Outcomes of Intravascular Ultrasound Guided versus Angiography Guided Complex High-Risk Indicated Percutaneous Coronary Intervention
Doctor R. Diletti (Rotterdam, NL)
Slides Video
Presentation thumbnail
Long-term clinical outcomes in patients with angina and non obstructive coronary artery disease undergoing comprehensive invasive coronary function testing
Doctor P. Damman (Nijmegen, NL)
Slides Video
Presentation thumbnail
Twenty-Year Outcomes of a Randomized Comparison between Percutaneous Coronary Intervention and Coronary Artery Bypass Grafting in Unprotected Left Main Stem Stenosis
Professor S. Desch (Leipzig, DE)
Slides Video

Access the full session

Session thumbnail
Better decisions in coronary revascularisation
Video

The Event

Event poster

ESC Congress 2026

31 August 2026 14:30 CET
You may be interested in
thumbnail
Congress Presentation
Ticagrelor monotherapy or DAPT after drug-eluting coronary stenting in patients with or without acute coronary syndrome: a patient-level meta-analysis of randomized controlled trials
31 August 2024
thumbnail
Congress Presentation
Incidence and pattern of repeat coronary revascularizations in patients with acute coronary syndromes treated with ticagrelor or prasugrel
27 August 2023
thumbnail
Congress Presentation
Is there a role for prasugrel monotherapy?
29 August 2026
thumbnail
Congress Presentation
Aspirin Discontinuation 1-month After PCI in Acute Myocardial Infarction: Individual-patient-data pooled analysis of the TARGET-FIRST and ULTIMATE-DAPT randomized trials
29 August 2026

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources